Novel crystalline compounds

The present invention relates to compounds CRYSTAL NOVEL TO BE ACTING AS kinase inhibitors, as the enzyme Janus Kinase 3 (JAK3) so they are useful in a wide variety of cases, such as agents immunosuppressants to organ transplants, xenotransplantation , lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, cancer, asthma, among others described in the application.